These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Dourado I, Cruz AA, Sant'Anna C, Bierrenbach AL, Barreto ML. Lancet; 2005 Oct 08; 366(9493):1290-5. PubMed ID: 16214599 [Abstract] [Full Text] [Related]
5. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children. Cunha SS, Dourado I, Barreto ML, Alexander N, Pereira SM, Ichihara Y, Pereira ES, Pedrosa V, Maroja F, Ribas C, Rodrigues LC. Int J Lepr Other Mycobact Dis; 2004 Mar 08; 72(1):8-15. PubMed ID: 15217320 [Abstract] [Full Text] [Related]
7. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence. Tala-Heikkilä MM, Tuominen JE, Tala EO. Am J Respir Crit Care Med; 1998 Apr 08; 157(4 Pt 1):1324-7. PubMed ID: 9563757 [Abstract] [Full Text] [Related]
9. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial. Cunha SS, Alexander N, Barreto ML, Pereira ES, Dourado I, Maroja Mde F, Ichihara Y, Brito S, Pereira S, Rodrigues LC. PLoS Negl Trop Dis; 2008 Feb 13; 2(2):e167. PubMed ID: 18270542 [Abstract] [Full Text] [Related]
10. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Lanckriet C, Lévy-Bruhl D, Bingono E, Siopathis RM, Guérin N. Int J Epidemiol; 1995 Oct 13; 24(5):1042-9. PubMed ID: 8557438 [Abstract] [Full Text] [Related]
11. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet; 1996 Jul 06; 348(9019):17-24. PubMed ID: 8691924 [Abstract] [Full Text] [Related]
12. Tuberculin reactivity in a population of schoolchildren with high BCG vaccination coverage. Bierrenbach AL, Cunha SS, Barreto ML, Pereira SM, Dourado I, Ichihara MY, Brito SC, Rodrigues LC. Rev Panam Salud Publica; 2003 May 06; 13(5):285-93. PubMed ID: 12831432 [Abstract] [Full Text] [Related]
14. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK. Mangtani P, Nguipdop-Djomo P, Keogh RH, Trinder L, Smith PG, Fine PE, Sterne J, Abubakar I, Vynnycky E, Watson J, Elliman D, Lipman M, Rodrigues LC. Health Technol Assess; 2017 Jul 06; 21(39):1-54. PubMed ID: 28738015 [Abstract] [Full Text] [Related]
16. [BCG vaccines for the prevention of tuberculosis in the world]. Hashimoto T. Kekkaku; 1997 Nov 06; 72(11):629-37. PubMed ID: 9423301 [Abstract] [Full Text] [Related]